Sulfameter

CHEMBL1200359 Phase 4 승인됨 Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

280.3 g/mol

LogP

0.4

Phase

4

Sulfameter is a very long-acting sulfonamide antibiotic with a plasma half-life of approximately 150 hours, used historically once or twice weekly for urinary tract infections and prevention of recurrent rheumatic fever. Its prolonged half-life results from slow renal excretion and extensive plasma protein binding. Like all sulfonamides, it inhibits bacterial dihydropteroate synthase. Its very long half-life increases the risk of cumulative sulfonamide toxicity.

분자량

280.3100 g/mol

LogP

0.40

TPSA

116.00 Å²

리핀스키 5의 법칙

통과

치료 영역

Benign Prostatic Hyperplasia Ophthalmology Asthma Schizophrenia Generalized Anxiety Disorder Nephrology Gastroesophageal Reflux Disease Stroke Lymphoma Heart Failure Atrial Fibrillation Colorectal Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D 구조

SVG PNG

Cite this structure

Embed this structure

SMILES

COc1cnc(NS(=O)(=O)c2ccc(N)cc2)nc1

InChI

InChI=1S/C11H12N4O3S/c1-18-9-6-13-11(14-7-9)15-19(16,17)10-4-2-8(12)3-5-10/h2-7H,12H2,1H3,(H,13,14,15)

Molecular Formula

C11H12N4O3S

HBD / HBA

2 / 7

회전 가능 결합

4

무거운 원자

19

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

Sulfameter is a very long-acting sulfonamide antibiotic with a plasma half-life of approximately 150 hours, used historically once or twice weekly for urinary tract infections and prevention of recurrent rheumatic fever. Its prolonged half-life results from slow renal excretion and extensive plasma protein binding. Like all sulfonamides, it inhibits bacterial dihydropteroate synthase. Its very long half-life increases the risk of cumulative sulfonamide toxicity.

Yes, Sulfameter is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200359. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 5326. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

환자 친화적 정보를 찾고 계신가요?

Sulfameter PillFYI에서

구조

핵심 데이터

분자식: C11H12N4O3S

외부 링크

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.